Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01:15 | Best Growth Stocks To Buy And Watch: See Updates To IBD Watchlists | ||
01:15 | AI-Chip Maker Broadcom Up 36% In Month: Find Top Stocks In IBD 50, Stock Spotlight, Other Watchlists | ||
00:45 | Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock | ||
00:15 | Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? | ||
Fr | Stock Market Gains On PCE Inflation Data; Is The Stage Set For A Santa Claus Rally? | ||
Fr | Vistra Takes Break After 264% Run; Is It Among IBD 50 Stocks To Sell? | ||
Fr | Dow Jones Futures: Bulls Fight Back After Market Sell-Off, Palantir Leads; What To Do Now | ||
Fr | The Swing Trading Solution When XLY Rebounded? Buy It Back. | ||
Fr | Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio? | ||
Fr | Nvidia, Tesla Showcase Timely Tips From Rudolph, Frosty And Scrooge | ||
Fr | Investing Action Plan: Navigating A Tricky Holiday Market | ||
Fr | DaVita Stock Sees Improved Relative Strength Rating | ||
Fr | Clorox Stock Gets Relative Strength Rating Lift | ||
Fr | This Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain | ||
Fr | Stock Market New Highs: Booming Avocado Sales Lift Mission Produce | ||
Fr | IBD Live Q&A, Stock Lists For Friday, Dec. 20, 2024 | ||
Fr | Birkenstock Approaches Buy Point Despite Stock Market Sell-Off | ||
Fr | Nvidia, AI Chip Stocks Get Lift From Bullish Morgan Stanley Report | ||
Fr | AppLovin, IBD Stock Of The Day, Earns Positive Reviews For New Service | ||
Fr | Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review | ||
Fr | The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks | ||
Fr | Airline Stocks And The Travel Industry's Record Rally. Here's The 2025 Outlook. | ||
Fr | Q4 Earnings Estimates Look Quite Strong For These IBD 50 Names, Including Palantir | ||
Fr | Dow Jones Jumps Nearly 400 Points As Government Shutdown Looms; Nvidia Rises While Tesla, Trump Shares Drop (Live Coverage) | ||
Fr | Palantir Stock Battles Back For A Gain Despite Valuation Worries |